Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...

On this episode of Uncanny Valley, we dive into the heated race between two companies to build a commercial brain-computer interface. Brain-computer interfaces might have inspired works of science ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Christopher Mims: Tim, what do you think is the hottest show on television right ...

Everyone – ourselves included – is talking about AI these days, for good reason. AI models now draft legal contracts, design chips, code software, edit videos, discover drugs, even run autonomous labs ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Researchers at MIT have invented "Circulatronics," a medical platform they say enables non-invasive treatment of ...

The technology works like a translator, not a mind reader – It converts brain scan patterns into coherent sentences by ...